| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Revenue | $3.84B | -2.8% |
| Cost of Revenue | $2.06B | -8.0% |
| Gross Profit | $1.78B | +4.0% |
| R&D Expense | $102.3M | +5.4% |
| SG&A Expense | $1.23B | +1.3% |
| Operating Income | $553.3M | +16.9% |
| Pre-tax Income | $548.6M | +22.8% |
| Income Tax | $126.0M | +25.1% |
| Net Income | $422.6M |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $845.8M | +112.6% |
| Accounts Receivable | $563.0M | +1.4% |
| Inventory | $387.6M | +5.2% |
| Current Assets | $1.87B | +34.1% |
| Total Assets | $3.81B | +11.9% |
| Current Liabilities | $687.9M | +15.5% |
| Long-term Debt | $496.2M | +0.1% |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $619.2M | +7.1% |
| Capital Expenditures | $64.0M | -4.0% |
| Investing Cash Flow | -$65.1M | +28.2% |
| Financing Cash Flow | -$104.5M | +66.6% |
| Free Cash Flow | $555.2M | +8.6% |
| +22.1% |
| EPS (Basic) | $13.68 | +25.7% |
| EPS (Diluted) | $13.44 | +24.9% |
| Total Liabilities |
| $1.44B |
| +3.1% |
| Stockholders' Equity | $2.38B | +18.0% |